(Total Views: 854)
Posted On: 08/10/2020 7:44:18 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
"gilead unveils what it calls "below market" pricing for its anti-viral drug remdesivir which so far has proven effective in treating covid-19"
https://www.thestreet.com/investing/gilead-su...vir-to-fda
https://www.thestreet.com/investing/gilead-su...vir-to-fda
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)